US Stock MarketDetailed Quotes
AFTPF AFT PHARMACEUTICALS LTD
- 0.000
- 0.0000.00%
15min DelayClose Sep 6 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)104.87MShares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM104.87MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
AFT PHARMACEUTICALS LTD Key Stats
Quarterly+Annual
YOY
| (FY)Mar 30, 2023 | (FY)Mar 30, 2022 | (FY)Mar 30, 2021 | (FY)Mar 30, 2020 | (FY)Mar 30, 2019 | (FY)Mar 30, 2018 | (FY)Mar 30, 2017 | (FY)Mar 30, 2016 | (Q4)Mar 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||||
| Cash flow from continuing operating activities | |||||||||
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | -64.32%-9.18M | 10.37%-5.59M | 5.04%-6.23M | -34.36%-6.56M | 16.58%-4.88M | -266.40%-5.86M | -130.26%-1.6M | -694K | -694K |
| Net PPE purchase and sale | 40.12%-197K | -253.76%-329K | -1.09%-93K | 34.29%-92K | -100.00%-140K | 42.62%-70K | 11.59%-122K | ---138K | ---138K |
| Net intangibles purchase and sale | -70.85%-8.98M | 14.37%-5.26M | 5.13%-6.14M | -94.59%-6.47M | -19.48%-3.33M | ---2.78M | ---- | ---556K | ---556K |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | 52.73%-1.42M | -250.70%-3M | ---856K | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---620K | ---- | ---- |
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | -64.32%-9.18M | 10.37%-5.59M | 5.04%-6.23M | -34.36%-6.56M | 16.58%-4.88M | -266.40%-5.86M | -130.26%-1.6M | ---694K | ---694K |
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | -78.28%-6.98M | -255.19%-3.91M | 127.66%2.52M | -344.91%-9.12M | -51.01%3.72M | -15.95%7.6M | -75.37%9.04M | 36.71M | 36.71M |
| Net issuance payments of debt | -251.49%-4M | 76.59%-1.14M | -129.34%-4.86M | -128.58%-2.12M | 3.95%7.42M | --7.14M | ---- | ---- | ---- |
| Net common stock issuance | 61.02%475K | -97.47%295K | 389,000.00%11.67M | --3K | ---- | -90.30%877K | -76.43%9.04M | --38.36M | --38.36M |
| Cash dividends paid | ---- | ---- | 66.78%-188K | -322.39%-566K | 67.48%-134K | ---412K | ---- | ---1.65M | ---1.65M |
| Net other financing activities | 33.71%-580K | 78.66%-875K | -699.42%-4.1M | -1,321.43%-513K | --42K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | -78.28%-6.98M | -255.19%-3.91M | 127.66%2.52M | -344.91%-9.12M | -51.01%3.72M | -15.95%7.6M | -75.37%9.04M | --36.71M | --36.71M |
| Net cash flow | |||||||||
| Beginning cash position | 147.43%7.94M | -47.56%3.21M | -11.52%6.12M | 2.16%6.92M | -57.43%6.77M | -43.31%15.91M | 496.91%28.06M | --4.7M | --4.7M |
| Current changes in cash | -197.27%-4.53M | 257.25%4.65M | -268.95%-2.96M | -753.19%-802K | 98.97%-94K | 21.17%-9.16M | -153.83%-11.62M | --21.58M | --21.58M |
| Effect of exchange rate changes | -257.69%-123K | 59.18%78K | 880.00%49K | -97.92%5K | 900.00%240K | 105.25%24K | -125.78%-457K | --1.77M | --1.77M |
| End cash Position | -58.55%3.29M | 147.43%7.94M | -47.56%3.21M | -11.52%6.12M | 2.16%6.92M | -57.63%6.77M | -43.04%15.98M | --28.06M | --28.06M |
| Free cash flow | -71.38%2.45M | 256.30%8.57M | -165.91%-5.48M | 446.79%8.32M | 82.57%-2.4M | 28.29%-13.76M | -26.77%-19.18M | ---15.13M | ---15.13M |
| Currency Unit | NZD | NZD | NZD | NZD | NZD | NZD | NZD | NZD | NZD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg